MACOM Reports Revenue of $114.9 Million With EPS $0.38 and Gross Margin of 53.7 Percent (Non-GAAP)
First Quarter Fiscal Year 2015 GAAP Results
-
Revenue was
$114.9 million , compared to$114.3 million in the prior fiscal quarter and$84.2 million in the previous year's fiscal first quarter; - Gross margin was 47.2 percent, compared to 49.2 percent in the prior fiscal quarter and 42.4 percent in the previous year's fiscal first quarter;
-
Operating income was
$9.1 million , compared to$16.8 million in the prior fiscal quarter and operating loss of$9.2 million in the previous year's fiscal first quarter; and -
Net loss was
$6.3 million , or$0.13 loss per share, compared to net income of$14.5 million , or$0.30 per diluted share, in the prior fiscal quarter and net loss of$8.9 million , or$0.19 loss per share, in the previous year's fiscal first quarter.
Inclusive in the GAAP results is a change in estimate related to MACOM's distribution revenue recognition, the net effect of which was a one-time increase of
First Quarter Fiscal Year 2015 Non-GAAP Results
- Gross margin was 53.7 percent, compared to 54.1 percent in the prior fiscal quarter and 46.6 percent in the previous year's fiscal first quarter;
-
Operating income was
$27.1 million , or 23.6 percent of revenue, compared to$26.7 million , or 23.3 percent of revenue, in the prior fiscal quarter and$16.2 million , or 19.4 percent of revenue, in the previous year's fiscal first quarter; -
EBITDA was
$30.6 million , compared to$30.0 million for the prior fiscal quarter and$19.2 million for the previous year's fiscal first quarter; and -
Net income was
$18.7 million , or$0.38 earnings per diluted share, compared to net income of$17.2 million , or$0.35 earnings per diluted share, in the prior fiscal quarter and net income of$12.1 million , or$0.25 earnings per diluted share, in the previous year's fiscal first quarter.
Business Outlook
For the fiscal quarter ending
Conference Call
MACOM will host a conference call today,
About MACOM:
Headquartered in
MACOM, M/
Special Note Regarding Forward-Looking Statements
This press release contains forward-looking statements based on MACOM management's beliefs and assumptions and on information currently available to our management. Forward-looking statements include, among others, information concerning our stated business outlook and future results of operations, and any statements regarding future trends, business strategies, competitive position, industry conditions, acquisitions and market opportunities. Forward-looking statements include all statements that are not historical facts and generally may be identified by terms such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "seeks," "should," "will," "would" or similar expressions and the negatives of those terms.
Forward-looking statements contained in this press release reflect MACOM's current views about future events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause those events or our actual activities or results to differ materially from those expressed in any forward-looking statement. Although MACOM believes that the expectations reflected in the forward-looking statements are reasonable, it cannot and does not guarantee future events, results, actions, levels of activity, performance or achievements. Readers are cautioned not to place undue reliance on these forward-looking statements. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements, including greater than expected dilutive effect on earnings of our outstanding indebtedness and related interest expense and
other costs, lower than expected demand in any or all of our four primary end markets or from any of our large OEM customers based on seasonal effects, macro-economic weakness or otherwise, our failure to realize the expected economies of scale, lowered production cost and other anticipated benefits of our previously announced GaN intellectual property licensing program, the potential for defense spending cuts, program delays, cancellations or sequestration, failures or delays by any customer in winning business or to make purchases from us in support of such business, lack of adoption or delayed adoption by customers and industries we serve of GaN, InP lasers or other solutions offered by us, failures or delays in porting and qualifying GaN or InP process technology to our
Non-GAAP Financial Measures
In addition to GAAP reporting, MACOM provides investors with non-GAAP financial information, including revenue, gross margin, operating margin, operating income, net income, earnings per share, EBITDA and other data calculated on a non-GAAP basis. This non-GAAP information excludes the operations of Nitronex prior to the date of acquisition, discontinued operations, the impact of fair value accounting in merger and acquisitions (M&A) of businesses, M&A costs, including acquisition and related integration costs, certain cost savings from synergies expected from M&A activities, income and expenses from transition services related to M&A activities, expected amortization of acquisition-related intangibles, share-based and other non-cash compensation expense, certain cash compensation, restructuring charges, litigation settlement and costs, changes in the carrying values of liabilities measured at fair value, contingent consideration, amortization of debt discounts and issuance costs, other non-cash expenses, earn-out costs, exited leased facility costs and certain income tax items. Management does not believe that the excluded items are reflective of MACOM's underlying performance. The exclusion of these and other similar items from MACOM's non-GAAP presentation should not be interpreted as implying that these items are non-recurring, infrequent or unusual. These and other similar items are also excluded from EBITDA, which is non-GAAP earnings before interest, income taxes, depreciation and amortization. MACOM believes this non-GAAP financial information provides additional insight into MACOM's on-going performance and has, therefore, chosen to provide this information to investors for a consistent basis of comparison and to help them evaluate the results of MACOM's on-going operations and enable more meaningful period to period comparisons. These non-GAAP measures are provided in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release.
|
|||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||
(unaudited and in thousands, except per share data) | |||
Three Months Ended | |||
2015 |
2014 |
2014 |
|
Revenue | $ 114,864 | $ 114,317 | $ 84,154 |
Cost of revenue | 60,663 | 58,128 | 48,432 |
Gross profit | 54,201 | 56,189 | 35,722 |
Operating expenses: | |||
Research and development | 19,474 | 20,098 | 12,430 |
Selling, general and administrative | 25,599 | 20,227 | 19,383 |
Restructuring charges | — | (902) | 13,090 |
Total operating expenses | 45,073 | 39,423 | 44,903 |
Income (loss) from operations | 9,128 | 16,766 | (9,181) |
Other income (expense): | |||
Accretion of common stock warrant liability | (10,608) | 1,638 | 1,282 |
Interest expense | (4,723) | (4,529) | (586) |
Other income - related party | 375 | 776 | 78 |
Total other income (expense) | (14,956) | (2,115) | 774 |
Income (loss) before income taxes | (5,828) | 14,651 | (8,407) |
Income tax provision (benefit) | 478 | 114 | (1,591) |
Income (loss) from continuing operations | (6,306) | 14,537 | (6,816) |
Loss from discontinued operations | — | — | (2,105) |
Net income (loss) | $ (6,306) | $ 14,537 | $ (8,921) |
Net income (loss) per share: | |||
Basic: | |||
Income (loss) from continuing operations | $ (0.13) | $ 0.31 | $ (0.15) |
Loss from discontinued operations | — | — | (0.05) |
Income (loss) per share - basic | $ (0.13) | $ 0.31 | $ (0.19) |
Diluted: | |||
Income (loss) from continuing operations | $ (0.13) | $ 0.30 | $ (0.15) |
Loss from discontinued operations | — | — | (0.05) |
Income (loss) per share - diluted | $ (0.13) | $ 0.30 | $ (0.19) |
Shares used to compute net income (loss) per share: | |||
Basic | 47,606 | 47,480 | 46,517 |
Diluted | 47,606 | 48,873 | 46,517 |
|
||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS | ||||||
(unaudited and in thousands, except per share data) | ||||||
Three Months Ended | ||||||
|
|
|
||||
Amount | Amount | Amount | ||||
Revenue - GAAP | $ 114,864 | $ 114,317 | $ 84,154 | |||
Nitronex prior to acquisition | — | — | (686) | |||
Revenue - Non-GAAP | $ 114,864 | $ 114,317 | $ 83,468 | |||
Amount | % Revenue | Amount | % Revenue | Amount | % Revenue | |
Gross profit - GAAP | $ 54,201 | 47.2% | $ 56,189 | 49.2% | $ 35,722 | 42.4% |
Nitronex prior to acquisition | — | — | — | — | 943 | 1.6 |
Amortization expense | 5,359 | 4.7 | 4,495 | 3.9 | 1,247 | 1.5 |
Non-cash compensation expense | 354 | 0.3 | 416 | 0.4 | 283 | 0.3 |
Equity-based compensation | 58 | — | 13 | — | — | — |
Acquisition FMV step-up | 835 | 0.7 | 168 | 0.1 | 536 | 0.6 |
Third-party engineering costs | (4) | — | 493 | 0.4 | — | — |
Integration costs and synergy savings | 924 | 0.8 | 100 | 0.1 | 139 | 0.2 |
Gross profit - non-GAAP | $ 61,727 | 53.7% | $ 61,874 | 54.1% | $ 38,870 | 46.6% |
Research and Development - GAAP | $ 19,474 | 17.0% | $ 20,098 | 17.6% | $ 12,430 | 14.8% |
Nitronex prior to acquisition | — | — | — | — | (985) | (1.1) |
Non-cash compensation expense | (1,038) | (0.9) | (713) | (0.6) | (484) | (0.6) |
Equity-based compensation | (519) | (0.5) | (112) | (0.1) | — | — |
Acquisition FMV step-up | (204) | (0.2) | (204) | (0.2) | (72) | (0.1) |
Integration costs and synergy savings | (171) | (0.1) | (898) | (0.8) | (36) | — |
Third-party engineering costs | 924 | 0.8 | 493 | 0.4 | — | — |
Research and Development - non-GAAP | $ 18,466 | 16.1% | $ 18,664 | 16.3% | $ 10,853 | 13.0% |
Selling, General and Administrative - GAAP | $ 25,599 | 22.3% | $ 20,227 | 17.7% | $ 19,383 | 23.0% |
Nitronex prior to acquisition | — | — | — | — | (494) | (0.3) |
Amortization expense | (1,053) | (0.9) | (432) | (0.4) | (366) | (0.4) |
Non-cash compensation expense | (2,405) | (2.1) | (1,623) | (1.4) | (1,078) | (1.3) |
Equity-based compensation | (317) | (0.3) | (106) | (0.1) | — | — |
Acquisition FMV step-up | (28) | — | (28) | — | (11) | — |
Litigation costs | (717) | (0.6) | (1,035) | (0.9) | (964) | (1.2) |
Transaction expenses | (4,636) | (4.0) | — | — | (4,222) | (5.1) |
Integration costs and synergy savings | (296) | (0.3) | (485) | (0.4) | (415) | (0.5) |
Selling, General and Administrative - non-GAAP | $ 16,147 | 14.1% | $ 16,518 | 14.4% | $ 11,833 | 14.2% |
Total operating expenses - GAAP | $ 45,073 | 39.2% | $ 39,423 | 34.5% | $ 44,903 | 53.4% |
Nitronex prior to acquisition | — | — | — | — | (1,479) | (1.3) |
Amortization expense | (1,053) | (0.9) | (432) | (0.4) | (366) | (0.4) |
Non-cash compensation expense | (3,443) | (3.0) | (2,336) | (2.0) | (1,562) | (1.9) |
Equity-based compensation | (836) | (0.7) | (218) | (0.2) | — | — |
Acquisition FMV step-up | (232) | (0.2) | (232) | (0.2) | (83) | (0.1) |
Restructuring charges | — | — | 902 | 0.8 | (13,090) | (15.7) |
Integration costs and synergy savings | (467) | (0.4) | (1,383) | (1.2) | (451) | (0.5) |
Litigation costs | (717) | (0.6) | (1,035) | (0.9) | (964) | (1.2) |
Transaction expenses | (4,636) | (4.0) | — | — | (4,222) | (5.1) |
Third-party engineering | 924 | 0.8 | 493 | 0.4 | — | — |
Total operating expenses - non-GAAP | $ 34,613 | 30.1% | $ 35,182 | 30.8% | $ 22,686 | 27.2% |
Income (loss) from operations - GAAP | $ 9,128 | 7.9% | $ 16,766 | 14.7% | $ (9,181) | (10.9)% |
Nitronex prior to acquisition | — | — | — | — | 2,422 | 2.9 |
Amortization expense | 6,412 | 5.6 | 4,927 | 4.3 | 1,613 | 1.9 |
Non-cash compensation expense | 3,797 | 3.3 | 2,752 | 2.4 | 1,845 | 2.2 |
Equity-based compensation | 894 | 0.8 | 231 | 0.2 | — | — |
Restructuring charges | — | — | (902) | (0.8) | 13,090 | 15.7 |
Acquisition FMV step-up | 1,067 | 0.8 | 400 | 0.3 | 619 | 0.7 |
Litigation costs | 717 | 0.6 | 1,035 | 0.9 | 964 | 1.2 |
Transaction expenses | 4,636 | 4.0 | — | — | 4,222 | 5.1 |
Integration costs and synergy savings | 463 | 0.6 | 1,483 | 1.3 | 590 | 0.7 |
Income from operations - non-GAAP | $ 27,114 | 23.6% | $ 26,692 | 23.3% | $ 16,184 | 19.4% |
Net income (loss) - GAAP | $ (6,306) | (5.5)% | $ 14,537 | 12.7% | $ (8,921) | (10.6)% |
Nitronex prior to acquisition | — | — | — | — | 2,422 | 2.8 |
Amortization expense | 5,258 | 4.6 | 3,769 | 3.3 | 1,234 | 1.5 |
Non-cash compensation expense | 3,113 | 2.7 | 2,105 | 1.8 | 1,411 | 1.7 |
Equity-based compensation | 733 | 0.6 | 177 | 0.2 | — | — |
Restructuring charges | — | — | (690) | (0.6) | 10,014 | 12.0 |
Warrant liability (gain) expense | 10,608 | 9.2 | (1,638) | (1.4) | (1,282) | (1.5) |
Non-cash interest expense | 360 | 0.3 | 291 | 0.3 | 91 | 0.1 |
Acquisition FMV step-up | 875 | 0.8 | 306 | 0.3 | 474 | 0.6 |
Litigation costs | 588 | 0.5 | 792 | 0.7 | 737 | 0.9 |
Integration costs and synergy savings | 380 | 0.3 | 1,134 | 1.0 | 451 | 0.5 |
Transaction expenses | 3,420 | 3.0 | — | — | 3,346 | 4.0 |
Tax effect of non-GAAP adjustments | — | — | (2,944) | (2.6) | — | — |
Transition services for divested business | (308) | (0.3) | (593) | (0.5) | — | — |
Discontinued operations | — | — | — | — | 2,105 | 2.5 |
Net income - non-GAAP | $ 18,721 | 16.3% | $ 17,246 | 15.1% | $ 12,082 | 14.5% |
Income from operations - non-GAAP | $ 27,114 | $ 26,692 | $ 16,184 | |||
Depreciation expense | 3,453 | 3,273 | 2,921 | |||
Other income, net | — | — | 78 | |||
EBITDA | $ 30,567 | $ 29,965 | $ 19,183 | |||
Interest expense GAAP | $ 4,723 | $ 4,529 | $ 586 | |||
Non cash interest expense | (439) | (361) | (119) | |||
Interest expense non-GAAP | $ 4,284 | $ 4,168 | $ 467 | |||
Three Months Ended | ||||||
|
|
|
||||
Amount |
Income (loss) per diluted share |
Amount |
Income per diluted share |
Amount |
Income (loss) per diluted share |
|
Net income (loss) - GAAP | $ (6,306) | $ (0.13) | $ 14,537 | $ 0.30 | $ (8,921) | $ (0.19) |
Net income - non-GAAP | $ 18,721 | $ 0.38 | $ 17,246 | $ 0.35 | $ 12,082 | $ 0.25 |
Diluted shares - GAAP | 47,606 | 47,480 | 46,517 | |||
Incremental stock options, warrants, restricted stock and units | 1,599 | 1,393 | 2,064 | |||
Diluted shares - non-GAAP | 49,206 | 48,873 | 48,581 |
|
||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||
(unaudited and in thousands) | ||
2015 |
2014 |
|
ASSETS | ||
Current assets: | ||
Cash and cash equivalents | $ 48,335 | $173,895 |
Accounts receivable, net | 79,452 | 75,156 |
Inventories | 89,208 | 73,572 |
Deferred income taxes | 35,956 | 79,257 |
Other current assets | 25,851 | 14,769 |
Total current assets | 278,802 | 416,649 |
Property and equipment, net | 59,393 | 50,357 |
Goodwill and intangible assets, net | 368,089 | 153,417 |
Deferred income taxes | 46,381 | 41,329 |
Other assets | 24,626 | 20,482 |
TOTAL ASSETS | $777,291 | $682,234 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||
Current liabilities: | ||
Current portion of long-term debt | $ 4,081 | $ 3,478 |
Accounts payable, accrued liabilities and other | 67,598 | 64,910 |
Deferred revenue | 219 | 17,258 |
Total current liabilities | 71,898 | 85,646 |
Long-term debt, less current portion | 443,248 | 343,178 |
Common stock warrant liability | 26,409 | 15,801 |
Deferred income taxes and other long-term liabilities | 8,714 | 9,042 |
Total liabilities | 550,269 | 453,667 |
Commitments and contingencies | ||
Stockholders' equity | 227,022 | 228,567 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $777,291 | $682,234 |
|
||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||
(unaudited and in thousands) | ||
Three Months Ended | ||
2015 |
2014 |
|
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net (loss) | $ (6,306) | $ (8,921) |
Non-cash adjustments | 25,716 | 5,975 |
Change in operating assets and liabilities | (17,327) | 5,284 |
Net cash from operating activities | 2,083 | 2,338 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Acquisition of businesses, net | (223,070) | (232,028) |
Purchases of property and equipment | (2,956) | (2,167) |
Acquisition of intellectual property | (1,056) | (2,983) |
Net cash used in investing activities | (227,082) | (237,178) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from revolving credit facility | 100,000 | 220,000 |
Payment of assumed debt | — | (32,864) |
Capital contributions | — | 2,100 |
Financing activities | 1,395 | 1,584 |
Payments on capital leases | (1,081) | — |
Term note payments | (875) | — |
Net cash from financing activities | 99,439 | 190,820 |
NET CHANGE IN CASH AND CASH EQUIVALENTS | (125,560) | (44,020) |
CASH AND CASH EQUIVALENTS — Beginning of period | 173,895 | 110,488 |
CASH AND CASH EQUIVALENTS — End of period | $ 48,335 | $ 66,468 |
CONTACT: Company Contact:Source:M/A-COM Technology Solutions Holdings, Inc. Robert J. McMullan Senior Vice President and Chief Financial Officer P: 978-656-2753 E: bobmcmullan@macom.com Investor Relations Contact:Shelton Group Leanne K. Sievers EVP, Investor Relations P: 949-224-3874 E: lsievers@sheltongroup.com
News Provided by Acquire Media